These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 32057086)
1. Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study. Lee S; Lee HH; Lee Y; Lee J J Rehabil Med; 2020 Feb; 52(2):jrm00025. PubMed ID: 32057086 [TBL] [Abstract][Full Text] [Related]
2. Effects of amantadine in children with impaired consciousness caused by acquired brain injury: a pilot study. McMahon MA; Vargus-Adams JN; Michaud LJ; Bean J Am J Phys Med Rehabil; 2009 Jul; 88(7):525-32. PubMed ID: 19404190 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of amantadine in children with impaired consciousness due to acquired brain injury: preliminary findings using a sparse-sampling technique. Vargus-Adams JN; McMahon MA; Michaud LJ; Bean J; Vinks AA PM R; 2010 Jan; 2(1):37-42. PubMed ID: 20129511 [TBL] [Abstract][Full Text] [Related]
4. Medical complications during inpatient rehabilitation among patients with traumatic disorders of consciousness. Whyte J; Nordenbo AM; Kalmar K; Merges B; Bagiella E; Chang H; Yablon S; Cho S; Hammond F; Khademi A; Giacino J Arch Phys Med Rehabil; 2013 Oct; 94(10):1877-83. PubMed ID: 23735519 [TBL] [Abstract][Full Text] [Related]
5. Does amantadine improve cognitive recovery in severe disorders of consciousness after aneurysmal subarachnoid hemorrhage? A double-blind placebo-controlled study. Gatto LAM; Demartini Z; Telles JPM; Figueiredo EG Clin Neurol Neurosurg; 2024 Feb; 237():108135. PubMed ID: 38330801 [TBL] [Abstract][Full Text] [Related]
6. Interpreting Change in Disorders of Consciousness Using the Coma Recovery Scale-Revised. Weaver JA; Cogan AM; Kozlowski AJ; Grady-Dominguez P; O'Brien KA; Bodien YG; Graham J; Aichele S; Ford P; Kot T; Bender Pape TL; Mallinson T; Giacino JT J Neurotrauma; 2024 Aug; 41(15-16):e1996-e2008. PubMed ID: 38613812 [TBL] [Abstract][Full Text] [Related]
7. Placebo-controlled trial of amantadine for severe traumatic brain injury. Giacino JT; Whyte J; Bagiella E; Kalmar K; Childs N; Khademi A; Eifert B; Long D; Katz DI; Cho S; Yablon SA; Luther M; Hammond FM; Nordenbo A; Novak P; Mercer W; Maurer-Karattup P; Sherer M N Engl J Med; 2012 Mar; 366(9):819-26. PubMed ID: 22375973 [TBL] [Abstract][Full Text] [Related]
8. Natural history of recovery from brain injury after prolonged disorders of consciousness: outcome of patients admitted to inpatient rehabilitation with 1-4 year follow-up. Katz DI; Polyak M; Coughlan D; Nichols M; Roche A Prog Brain Res; 2009; 177():73-88. PubMed ID: 19818896 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and electroencephalographic effects of amantadine sulfate (PK-Merz) on consciousness disorders due to the severe traumatic brain injury]. Cheliapina MV; Sharova EV; Zaĭtsev OS Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):24-9. PubMed ID: 21666589 [TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients with prolonged disorders of consciousness after brain injury: a longitudinal cohort study. Yan D; Simei L; Hongzhao B; Hongyan D; Yuchao D Front Public Health; 2024; 12():1421779. PubMed ID: 39114510 [TBL] [Abstract][Full Text] [Related]
12. Assessment of Nociception and Pain in Participants in an Unresponsive or Minimally Conscious State After Acquired Brain Injury: The Relation Between the Coma Recovery Scale-Revised and the Nociception Coma Scale-Revised. Chatelle C; Hauger SL; Martial C; Becker F; Eifert B; Boering D; Giacino JT; Laureys S; Løvstad M; Maurer-Karattup P Arch Phys Med Rehabil; 2018 Sep; 99(9):1755-1762. PubMed ID: 29653106 [TBL] [Abstract][Full Text] [Related]
13. Amantadine, apomorphine and zolpidem in the treatment of disorders of consciousness. Gosseries O; Charland-Verville V; Thonnard M; Bodart O; Laureys S; Demertzi A Curr Pharm Des; 2014; 20(26):4167-84. PubMed ID: 24025057 [TBL] [Abstract][Full Text] [Related]
14. Specialized early treatment for persons with disorders of consciousness: program components and outcomes. Seel RT; Douglas J; Dennison AC; Heaner S; Farris K; Rogers C Arch Phys Med Rehabil; 2013 Oct; 94(10):1908-23. PubMed ID: 23732166 [TBL] [Abstract][Full Text] [Related]
15. Amantadine: a potential treatment for the minimally conscious state. Zafonte RD; Watanabe T; Mann NR Brain Inj; 1998 Jul; 12(7):617-21. PubMed ID: 9653525 [TBL] [Abstract][Full Text] [Related]
16. Disorders of Consciousness. Eapen BC; Georgekutty J; Subbarao B; Bavishi S; Cifu DX Phys Med Rehabil Clin N Am; 2017 May; 28(2):245-258. PubMed ID: 28390511 [TBL] [Abstract][Full Text] [Related]
17. Pharmacology in Treatment of Patients with Disorders of Consciousness. Marino MH Phys Med Rehabil Clin N Am; 2024 Feb; 35(1):155-165. PubMed ID: 37993186 [TBL] [Abstract][Full Text] [Related]
18. Effects of Cerebrolysin® in Patients With Minimally Conscious State After Stroke: An Observational Retrospective Clinical Study. Kim JY; Kim HJ; Choi HS; Park SY; Kim DY Front Neurol; 2019; 10():803. PubMed ID: 31428035 [No Abstract] [Full Text] [Related]
20. Implications of the Consciousness State on Decannulation in Patients With a Prolonged Disorder of Consciousness. Draghi F; Pancani S; De Nisco A; Romoli AM; Maccanti D; Burali R; Grippo A; Macchi C; Cecchi F; Hakiki B Arch Phys Med Rehabil; 2024 Sep; 105(9):1691-1699. PubMed ID: 38734048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]